These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26289486)

  • 1. The safety, efficacy and tolerability of Abilify Maintena for the treatment of schizophrenia.
    Kahn RS; Giannopoulou A
    Expert Rev Neurother; 2015; 15(9):969-81. PubMed ID: 26289486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schizophrenia relapse and the clinical usefulness of once-monthly aripiprazole depot injection.
    Wang SM; Han C; Lee SJ; Patkar AA; Masand PS; Pae CU
    Neuropsychiatr Dis Treat; 2014; 10():1605-11. PubMed ID: 25210454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aripiprazole long-acting injectable formulations for schizophrenia: aripiprazole monohydrate and aripiprazole lauroxil.
    Citrome L
    Expert Rev Clin Pharmacol; 2016; 9(2):169-86. PubMed ID: 26573020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aripiprazole (ABILIFY MAINTENA®): a review of its use as maintenance treatment for adult patients with schizophrenia.
    Shirley M; Perry CM
    Drugs; 2014 Jul; 74(10):1097-110. PubMed ID: 24969315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly.
    Biagi E; Capuzzi E; Colmegna F; Mascarini A; Brambilla G; Ornaghi A; Santambrogio J; Clerici M
    Adv Ther; 2017 May; 34(5):1036-1048. PubMed ID: 28382557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A safety evaluation of aripiprazole in the treatment of schizophrenia.
    Preda A; Shapiro BB
    Expert Opin Drug Saf; 2020 Dec; 19(12):1529-1538. PubMed ID: 33064050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aripiprazole once-monthly long-acting injectable for the treatment of schizophrenia.
    Potkin SG; Preda A
    Expert Opin Pharmacother; 2016; 17(3):395-407. PubMed ID: 26864352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aripiprazole intramuscular depot as maintenance treatment in patients with schizophrenia: a 52-week, multicenter, randomized, double-blind, placebo-controlled study.
    Kane JM; Sanchez R; Perry PP; Jin N; Johnson BR; Forbes RA; McQuade RD; Carson WH; Fleischhacker WW
    J Clin Psychiatry; 2012 May; 73(5):617-24. PubMed ID: 22697189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of aripiprazole long-acting injection.
    Chue P; Chue J
    Curr Med Res Opin; 2016; 32(3):441-52. PubMed ID: 26713457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of aripiprazole lauroxil once-monthly versus aripiprazole once-monthly long-acting injectable formulations in patients with acute symptoms of schizophrenia: an indirect comparison of two double-blind placebo-controlled studies.
    Cameron C; Zummo J; Desai D; Drake C; Hutton B; Kotb A; Weiden PJ
    Curr Med Res Opin; 2018 Apr; 34(4):725-733. PubMed ID: 29179595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Acting Injectable (LAI) Aripiprazole Formulations in the Treatment of Schizophrenia and Bipolar Disorder: a Systematic Review.
    Rapinesi C; Kotzalidis GD; Mazzarini L; Brugnoli R; Ferracuti S; De Filippis S; Cuomo I; Giordano G; Del Casale A; Angeletti G; Sani G; Girardi P
    Clin Drug Investig; 2019 Aug; 39(8):713-735. PubMed ID: 31152368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and effectiveness of depot versus oral antipsychotics in schizophrenia: synthesizing results across different research designs.
    Kirson NY; Weiden PJ; Yermakov S; Huang W; Samuelson T; Offord SJ; Greenberg PE; Wong BJ
    J Clin Psychiatry; 2013 Jun; 74(6):568-75. PubMed ID: 23842008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-acting injectable risperidone for the treatment of schizophrenia: clinical perspectives.
    Möller HJ
    Drugs; 2007; 67(11):1541-66. PubMed ID: 17661527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aripiprazole long-acting injection: promising but more evidence needed.
    Keks NA; Hope J; Culhane C
    Australas Psychiatry; 2016 Aug; 24(4):368-70. PubMed ID: 26906437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Going the distance: reviewing antipsychotic depot or long-acting injectable treatments in Australasia.
    Theodoros T; Taylor M; Huang HC; Wang N; Motamarri B
    Australas Psychiatry; 2018 Jun; 26(3):303-306. PubMed ID: 29457473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of aripiprazole long-acting injectable antipsychotic on hospitalization in recent-onset schizophrenia.
    Karlović D; Silić A; Crnković D; Peitl V
    Hum Psychopharmacol; 2021 Mar; 36(2):e2763. PubMed ID: 33058260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aripiprazole Lauroxil Long-Acting Injectable: The Latest Addition to Second-Generation Long-Acting Agents.
    Aggarwal A; Gopalakrishna G; Lauriello J
    Clin Schizophr Relat Psychoses; 2016; 10(1):58-63. PubMed ID: 27074333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral versus depot antipsychotic drugs for schizophrenia--a critical systematic review and meta-analysis of randomised long-term trials.
    Leucht C; Heres S; Kane JM; Kissling W; Davis JM; Leucht S
    Schizophr Res; 2011 Apr; 127(1-3):83-92. PubMed ID: 21257294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
    Swainston Harrison T; Perry CM
    Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching long acting antipsychotic medications to aripiprazole long acting once-a-month: expert consensus by a panel of Italian and Spanish psychiatrists.
    Fagiolini A; Alfonsi E; Amodeo G; Cenci M; Di Lella M; Farinella F; Ferraiuolo F; Fraguas D; Loparco N; Gutierrez-Rojas L; Mignone ML; Pataracchia G; Pillai G; Russo F; Sanchez-Gistau V; Spinogatti F; Toscano M; Villari V; De Filippis S
    Expert Opin Drug Saf; 2016; 15(4):449-55. PubMed ID: 26886162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.